This activity is supported by an unrestricted educational grant from Bristol-Myers Squibb and Merck & Co.
Evolving Paradigms in Melanoma Therapy
Anthony J. Olszanski, MD, RPH,
Fox Chase Cancer Center
Brianna Hoffner, MS, ANP-BC, AOCNP
The Angeles Clinic and Research Institute
Learn the science behind immune response and treatment options for Melanoma. This activity provides an overview of differentiating checkpoint inhibitors from options such as kinase inhibitors, and cytotoxic chemotherapy. Discuss potential toxicities, care management, and the AP role in the collaborative practice approach to patient care.
These CE/CME/CEU accredited activities are jointly provided by